IDEOlogy Health, a provider of non-promotional, multi-channel medical education to oncology professionals, on Tuesday announced two exclusive strategic partnership agreements with West Cancer Center & Research Institute, designed to elevate physician and Advanced Practice Provider (APP) education.
Together, these collaborations aim to strengthen oncology care delivery and improve outcomes for patients across the community.
West Cancer Center & Research Institute offers advanced treatments, innovative therapies, and comprehensive patient support services, all grounded in research-driven and compassionate care.
By combining IDEOlogy Health's innovative educational platforms with West's clinical expertise, the collaboration aims to help accelerate the integration of emerging research into everyday clinical practice, ensuring patients benefit from the latest scientific advancements, regardless of where they receive care.
Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints
Gilead to acquire Tubulis to expand ADC oncology capabilities
FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer
Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP
Aelis Farma secures EUR458k France 2030 grant to advance metabolic disease programme
Immedica Pharma gains European approval to extend Efmody use in adrenal insufficiency
NeuroSense's PrimeC composition receives Brazilian patent
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development
Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal
NJ Bio and Aji Bio-Pharma partner to strengthen support for ADC development
Alltrna granted approval for first-in-human clinical trial of AP003